...
首页> 外文期刊>Advances in Interventional Cardiology: Postepy w Kardiologii Interwencyjnej >New treatment possibilities for patients with advanced coronary artery disease and critical limb ischemia – a feasibility study
【24h】

New treatment possibilities for patients with advanced coronary artery disease and critical limb ischemia – a feasibility study

机译:晚期冠状动脉疾病和严重肢体缺血患者的新治疗可能性–可行性研究

获取原文

摘要

Atherosclerosis can be limited to one vascular bed, but more often it takes a diffused form. Detection of the disease in one area should prompt further assessment of the patient for atherosclerotic disease in different territories. According to various studies, in patients over 50 years old with peripheral artery disease (PAD), critical limb ischemia (CLI) affects 1–2% of this population. These patients have very high risk of cardiovascular events due to concomitant coronary and cerebrovascular disease (5-year event rate of 20%), and it has been proven that those events occur more frequently than ischemic events of the lower extremities, regardless of the stage of the lower extremity arterial disease (LEAD). Furthermore, over the 5-year observation period, 75% of deaths are caused precisely by cardiovascular events [1]. Prevalence of coronary and carotid artery disease in patients with LEAD, as reported by various studies, is between 50% and 60%. In the authors’ registry of 218 patients with peripheral artery disease undergoing diagnostic coronary angiography, significant co-existing coronary artery disease was diagnosed in patients with LEAD or carotid artery disease in 63% and 65% respectively. It is interesting that 72% of those patients had never had any coronary artery disease (CAD) symptoms. Detection of concomitant CAD in patients with LEAD is especially important before planning the surgical strategy. Peripheral vascular surgery is considered a high-risk surgery, with the highest risk of cardiac complications (estimated 30-day cardiac event rates – cardiac death and myocardial infarction (MI) – of over 5%) [2–9]. According to the above data, detailed cardiac evaluation of patients with LEAD undergoing vascular surgery should be performed routinely and become a standard of care. Patients with CLI have worse prognoses than patients with different forms of malignant diseases and, as yet, no way has been found to improve these prognoses. Overall, mortality in patients with CLI approaches 50% at 5 years and 70% at 10 years [1]. Because of that, in our facility diagnostic peripheral angiography in patients with CLI is followed by routine coronary angiography. Our planned strategy for patients with CLI requiring immediate vascular surgery and diagnosed with advanced coronary artery disease (critical narrowing of main coronary artery) was hybrid treatment. The benefit of one-stage treatment is diminishing the risk of... View full text...
机译:动脉粥样硬化可局限于一个血管床,但更多情况下呈扩散形式。在一个地区发现该疾病应促使进一步评估患者在不同地区的动脉粥样硬化疾病。根据各种研究,在50岁以上患有外周动脉疾病(PAD)的患者中,严重肢体缺血(CLI)影响了这一人群的1-2%。这些患者由于合并的冠心病和脑血管疾病而具有很高的心血管事件风险(5年事件发生率为20%),并且已经证明,无论何种阶段,这些事件都比下肢缺血事件更频繁地发生下肢动脉疾病(LEAD)。此外,在5年的观察期内,有75%的死亡正是由心血管事件引起的[1]。据各种研究报道,LEAD患者的冠状动脉和颈动脉疾病患病率在50%至60%之间。在作者对218例接受诊断性冠状动脉造影的外周动脉疾病患者的登记中,LEAD或颈动脉疾病患者中诊断出明显并存的冠状动脉疾病分别为63%和65%。有趣的是,这些患者中有72%从未出现任何冠状动脉疾病(CAD)症状。在计划手术策略之前,LEAD患者伴发CAD的检测尤为重要。周围血管手术被认为是高风险手术,发生心脏并发症的风险最高(估计的30天心脏事件发生率–心脏死亡和心肌梗塞(MI)–超过5%)[2-9]。根据上述数据,应常规对接受血管外科手术的LEAD患者进行详细的心脏评估,并将其作为护理标准。患有CLI的患者的预后要比患有各种形式的恶性疾病的患者差,并且迄今尚未找到改善这些预后的方法。总体而言,CLI患者的死亡率在5年时接近50%,在10年时接近70%[1]。因此,在我们的设施中,CLI患者的诊断性外周血管造影是常规的冠状动脉造影。对于需要立即进行血管外科手术且被诊断患有晚期冠状动脉疾病(主要冠状动脉严重狭窄)的CLI患者,我们计划的策略是混合治疗。一阶段治疗的好处是减少了...的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号